This panel, originally recorded in front of a live audience at SXSW 2023, discusses innovative data sources for clinical trial recruitment and how to maximize their effectiveness. The panel explores a range of innovative data sources, such as online platforms, real world data and social networks, and how they can be used to find the right candidates for a study. The panelists discuss the advantages and disadvantages of different data sources, such as the potential cost savings, access to a larger pool of potential participants and the ability to target specific populations. They also discuss potential ethical considerations, such as protecting participant privacy and ensuring that the data used is accurate and up-to-date. Panelists Bryan Hansen, Director of Data Science & Digital Health Neuroscience, Johnson & Johnson Maimah Karmo, CEO & President, Tigerlily Foundation Joan Severson, Chief Innovation Officer, Clinical Ink Aaron Strout, Chief Marketing Officer, Real Chemistry (Host)

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related